| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.67 | 0.02 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.22 | 0.04 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.08 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.08 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.13 | 0.7 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |